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rapid eye Movement sleep 
Deprivation induces neuronal 
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on alpha1 adrenoceptor and by 
Triggering Mitochondrial intrinsic 
Pathway
Bindu I. Somarajan , Mudasir A. Khanday and Birendra N. Mallick*
School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
Many neurodegenerative disorders are associated with rapid eye movement sleep 
(REMS) loss; however, the mechanism was unknown. As REMS loss elevates noradren-
aline (NA) level in the brain as well as induces neuronal apoptosis and degeneration, 
in this study, we have delineated the intracellular molecular pathway involved in REMS 
deprivation (REMSD)-associated NA-induced neuronal apoptosis. Rats were REMS 
deprived for 6 days by the classical flower pot method; suitable controls were con-
ducted and the effects on apoptosis markers evaluated. Further, the role of NA was 
studied by one, intraperitoneal (i.p.) injection of NA-ergic alpha1 adrenoceptor antago-
nist prazosin (PRZ) and two, by downregulation of NA synthesis in locus coeruleus (LC) 
neurons by local microinjection of tyrosine hydroxylase siRNA (TH-siRNA). Immunoblot 
estimates showed that the expressions of proapoptotic proteins viz. Bcl2-associated 
death promoter protein, apoptotic protease activating factor-1 (Apaf-1), cytochrome c, 
caspase9, caspase3 were elevated in the REMS-deprived rat brains, while caspase8 
level remained unaffected; PRZ treatment did not allow elevation of these proapoptotic 
factors. Further, REMSD increased cytochrome c expression, which was prevented 
if the NA synthesis from the LC neurons was blocked by microinjection of TH-siRNA 
in vivo into the LC during REMSD in freely moving normal rats. Mitochondrial damage 
was re-confirmed by transmission electron microscopy, which showed distinctly swol-
len mitochondria with disintegrated cristae, chromosomal condensation, and clumping 
along the nuclear membrane, and all these changes were prevented in PRZ-treated 
rats. Combining findings of this study along with earlier reports, we propose that upon 
REMSD NA level increases in the brain as the LC, NA-ergic REM-OFF neurons do not 
cease firing and TH is upregulated in those neurons. This elevated NA acting on alpha1 
adrenoceptors damages mitochondria causing release of cytochrome c to activate 
intrinsic pathway for inducing neuronal apoptosis in REMS-deprived rat brain.
Keywords: BaD, caspases, cytochrome c, locus coeruleus, neuronal degeneration
Abbreviations: Apaf-1, apoptosis protease activating factor-1; BAD, Bcl-2-associated death promoter; BAX, Bcl-2-associated X 
protein; Bcl2, B-cell lymphoma 2; LC, locus coeruleus; NREMS, non-REMS; pAkt, phosphorylated Akt (Ser 478); REMS, rapid 
eye movement sleep; REMSD, REMS deprivation; siRNA, small interfering RNA; TH, tyrosine hydroxylase.
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inTrODUcTiOn
Our understanding about the causes and mechanism of action 
of the neurodegenerative diseases is still poor. For a comprehen-
sive understanding, a thorough knowledge of their cause and 
effect as well as their cellular and molecular mechanism(s) of 
occurrence, preferably in vivo was needed. Many such diseases 
including Alzheimer’s, Parkinson’s, etc., are related to aging, 
whose population is rising exponentially throughout the world. 
Aging-associated disorders so to say are inevitable; however, 
their expressions depend on predisposition and susceptibility, 
which are modulated by changes in one or more fundamental 
physiological processes. One of the common fundamental physi-
ological processes affected in most such disorders is changes in 
sleep–waking, which is also affected by lifestyle and vice versa. 
Sleep has been divided into rapid eye movement sleep (REMS) 
and non-REMS, and as a common factor, at least the former is 
affected in most of the psychosomatic and neurodegenerative 
disorders. We have shown earlier that experimental REMS 
deprivation (REMSD) affects neuronal cytomorphology and 
structural protein leading to neuronal apoptosis and loss, and 
these effects were mediated by REMSD-associated elevation in 
the level of noradrenaline (NA) in the brain (1–3). Our conten-
tion gets supported by a recent report in humans that gray matter 
volume is reduced upon sleep disturbance (4). The NA level in 
the brain is affected after REMSD (5, 6) and elevated NA has 
been reported to affect many of the REMSD (including total sleep 
loss)-associated effects, for example, thermoregulation (7), feed-
ing (8), irritability and excitability (9), learning and memory (10), 
and psychosomatic disorders (11–13). A pathological condition 
characterized by death of neurons in the dorsal raphe nucleus 
and locus coeruleus (LC) in Alzheimer’s and Parkinson’s disease 
is also observed where REMS loss is a common phenomenon. 
Our previous study showed changes in BAX and Bcl2 proteins in 
REMSD rat brain (1–3), indicating a possibility of involvement of 
mitochondria-associated proteins in REMSD-induced apoptosis. 
As there was a need to understand the molecular mechanism of 
REMSD-associated neurodegeneration, in this study, we have 
investigated the intracellular mechanism of REMSD-associated 
NA-induced neuronal apoptosis in the rat brain. We have 
observed that REMSD-associated neuronal apoptosis followed 
mitochondrial intrinsic pathway by releasing cytochrome c and 
by affecting the Akt survival pathway. Further, the role of NA in 
inducing such apoptosis was confirmed in vivo; one, by blocking 
adrenoceptors and two, by downregulation of NA synthesis in 
REMS-deprived rat brains.
MaTerials anD MeThODs
animals and reMs Deprivation
A total of 55 adult male Wistar rats (250–280 g) maintained under 
12:12 light:dark cycle at controlled temperature (25 ± 1°C) in 
standard laboratory conditions having free access to ad  libi-
tum food and water were used in this study. All experimental 
procedures were approved by the Institutional Animal Ethics 
Committee of the Jawaharlal Nehru University, New Delhi, 
India. Free moving control (FMC) rats (N = 5) were maintained 
in their normal dry home cages. The rats (N = 5) were REMS 
deprived by the classical flower pot method for 6  days (14, 
15). In brief, the experimental rats were maintained on 6.5-cm 
diameter platform surrounded by water. In order to exclude the 
effects of non-specific confounding factors, a separate group 
of rats (N = 5) were maintained on larger platform of 12.5-cm 
diameter, the large platform control (LPC) group. The recovery 
(REC) group included animals (N = 5) deprived of REMS for 
6 days and then allowed to live in normal cages for 3 days to 
recover from lost REMS. In another set (N = 5), 2 mg/kg/day 
prazosin (PRZ) was i.p. injected between 10:00 and 11:00 a.m. 
into the rats on each day of the last 4 days (i.e., third to sixth 
day) of 6-day REMSD schedule as before (3). At the end of the 
experiments, the rats were sacrificed between 10:00 and 11:00 
a.m. by cervical dislocation, and the brains were taken out for 
further studies.
stereotaxic surgery
Under isofluorane- (Baxter, Baxter Healthcare Corporation of 
Puerto Rico, USA) induced surgical anesthesia and aseptic condi-
tion, rats were stereotaxically implanted with stainless steel guide 
cannulae bilaterally targeting the LC (AP = −9.68, L = 1.3, and 
H =  7.4) (16, 17). The guide cannulae were advanced into the 
brain so that their tips in the brain reached 1 mm above the target 
and fixed to the skull with dental acrylic cement. About a week 
was allowed with adequate post-operative care to recover the rats 
from postsurgical trauma before experiments were conducted on 
them (18).
reMsD and Microinjection of  
Th-sirna into lc
Morphological changes associated with neuronal apoptosis could 
be observed only after 144 h REMSD; however, the molecular 
signaling cascade of apoptosis may commence with initiation of 
increased NA level during REMSD. Therefore, we conducted the 
tyrosine hydroxylase siRNA (TH-siRNA) experiment for 96  h 
so that distress to the experimental rats was minimized. After 
recovery from surgical trauma, the chronically prepared rats 
were divided into three groups of five rats each: FMC which did 
not receive any microinjection (treatment), 96 h REMS deprived 
which received control siRNA (Ambion, USA) bilaterally into 
the LC. The sense-5′CUGUGAAGUUUGACCCGUAtt-3′ and 
antisense-5′UACGGGUCAAACUUCACAgg-3′ TH-siRNA 
(Sigma, USA) were incubated with N-TER (Sigma, USA) 
for 30  min before injection. During the REMSD period for 
two consecutive days, 0.5  μl containing 0.01  nmol of either 
TH-siRNA or control siRNA was bilaterally microinjected into 
the LC (Figure  1) at the end of 24 and 48  h of REMSD and 
deprivation continued for a total of 96 h. The microinjections 
into the LC in the chronically prepared freely moving otherwise 
normally behaving rats were done as described earlier (16, 17). 
Briefly, it was done using a 33G stainless steel injector smoothly 
passing through the guide cannulae already implanted into the 
rat brain. The injector had a stopper arrangement so that when 
introduced through the guide cannulae, the tip of the injector 
FigUre 1 | schematic representation of microinjection of Th-sirna and control sirna in vivo bilaterally into the lc of freely moving normally 
behaving surgically prepared chronic rats.
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projected 1 mm out of the guide cannulae inside the brain to 
reach the target, the LC. A 2-μl Hamilton syringe was connected 
to the injector with approximately 10  cm polyethylene tubing 
containing the solution to be injected. The rat was held briefly 
for a period of about 5–6  min during microinjection on each 
side LC; there was a gap of about 5  min between injections 
into each side. After completion of experiment, the rats were 
sacrificed between 10:00 and 11:00 a.m. by cervical dislocation, 
and the brains were taken out for further analysis. As the study 
demanded, the rat brains to be homogenized for other protein 
assays, it was a technical limitation to confirm the injection site 
histologically in the brains of the same rat. As an alternative, we 
evaluated TH band intensity by Western blot in samples from 
brain homogenate in experimental and control rat brains. As 
LC is the primary site for NA-ergic neurons in the brain and all 
other conditions remaining identical (except microinjection of 
TH-siRNA and control siRNA into the LC in control and experi-
mental rats), the TH-band density in the Western blot reflected 
the TH expressions in the LC neurons. This was supported in 
pilot studies where the microinjection site was histologically 
confirmed in the LC (Figure 1).
electron Microscopy
Experimental rats were intracardially perfused, and approxi-
mately 1 mm thick brain tissue blocks having LC, as per the atlas 
of Paxinos and Watson (19), were cut as reported earlier (1) and 
fixed for 24 h in Karnowsky fixative (2% paraformaldehyde and 
2% glutaraldehyde solution; pH 7.2). The blocks were then trans-
ferred into PBS and subsequently processed for transmission 
electron microscopy (TEM) at the Advanced Instrumentation 
Research Facility of Jawaharlal Nehru University. The tissues 
were post-fixed in 1% osmium tetroxide (Sigma, USA) for 2 h 
at 4°C, dehydrated in grades of ethanol, and cleared in toluene 
before preparing araldite blocks for ultra-thin sectioning. The 
sections were collected on metal grids and stained using uranyl 
acetate and lead citrate. After washing in distilled water, the grids 
were stored in airtight petri plates for viewing under TEM. TEM 
experiments included N = 15, three rats in each group of FMC, 
LPC, REMSD, REC, and PRZ.
antibody and reagents
Rabbit polyclonal primary antibodies anti-Apaf-1 (ab2001), anti-
Bcl2-associated death promoter (BAD) (ab90435), anti-Caspase3 
(ab47131), anti-Caspase9 (ab2324), and anti-pAkt (ab66138) were 
commercially obtained from Abcam (Cambridge, UK). Anti-TH 
(AB152), anti-caspase8 (AB1879), and anti-Cytochrome c (3025-
100) were purchased from Millipore, CA, USA and Biovision, CA, 
USA, respectively. Horseradish peroxidase (HRP)-conjugated 
goat anti-rabbit secondary antibodies (sc-3837) were purchased 
from Santa Cruz Biotechnology, USA. Monoclonal mouse 
anti-tubulin antibody (05-829) from Millipore, USA was used 
for loading control. PRZ was procured from Sigma-Aldrich, St. 
Louis, MO, USA.
immunoblotting
At the end of the experiment, the control and the experimen-
tal rats were decapitated after spinal dislocation. The brains 
(including the cerebellum and brainstem) were quickly removed 
individually and homogenized separately in 10-ml ice cold 
homogenization buffer containing 0.32M sucrose, 12 mM Tris 
(pH 7.4), and 1 mM EDTA. The brain homogenate was centri-
fuged at 3000 × g (6000  rpm) for 5 min at 4°C to remove the 
larger debris. The supernatant was centrifuged at 11,000  ×  g 
(12,000  rpm) for 20  min at 4°C. After centrifugation, 2  ml of 
the supernatant was carefully removed for Western blotting; 
protein concentration was determined by Lowry’s method (20). 
For Western blotting, equal amount of proteins were loaded in 
separate wells in 8 or 10% polyacrylamide gels and allowed to 
FigUre 2 | BaD expression in the brain homogenate of rats under 
different conditions. Upper panel shows a representative Western blot of 
BAD expressions in the brain of rats exposed to various control and 
experimental (REMSD) conditions. Histogram in the lower panel shows 
percent changes in the mean (±SEM) band densities of the blots as 
compared to FMC taken as 100% in five sets of experiments. Abbreviations 
are as in the text. Significance levels are between the treatments of 
connecting horizontal bars; ***p < 0.001 and ###p < 0.001, * as compared to 
FMC and # as compared to REMSD.
March 2016 | Volume 7 | Article 254
Somarajan et al. REMS Loss Causes Neuronal Apoptosis
Frontiers in Neurology | www.frontiersin.org
run electrophoretically using standard SDS-PAGE protocol (21, 
22). Following electrophoresis, the separated proteins on the gels 
were electrotransferred on to 0.45-μm nitrocellulose membrane 
(MDI, India) using a Trans-Blot SD (Bio-Rad, USA). After block-
ing the membranes with 3% BSA in Tris-buffered saline (TBS) 
for 3  h at room temperature, the membranes were incubated 
overnight at 4°C with primary antibodies. The membranes were 
then washed with TBS containing 0.1% Tween-20 (TBS-T) and 
probed with appropriate HRP-conjugated secondary goat anti-
rabbit antibody for 1.5 h at room temperature. After secondary 
antibody incubation, the membranes were washed three times 
with TBS-T followed by with TBS. Protein expressions were 
visualized by enhanced chemiluminescence method using 
Clarity™ (Bio-Rad, USA). The band densities (after background 
subtraction) on the film were estimated using alpha image 
software (Alpha Innotech, USA). As the α-tubulin band intensi-
ties among the controls and experimental rat brain samples 
were comparable, the relative changes in the intensity of each 
of the protein bands of interest under various conditions (LPC, 
REMSD, REC, PRZ, control-siRNA and TH-siRNA) in every gel 
were estimated against respective FMC band intensity taken as 
100% for normalization.
statistics
Data were collected from five independent sets of experiments; 
each set consisted of one rat from each group and the values have 
been expressed as mean ±  SEM. The differences in the mean 
intensities of the protein bands of interest between experimental 
and control rat brains were statistically compared with that of the 
FMC using Sigma Stat Statistical Software version 12. As one-way 
ANOVA did not show any significant intra-group variation, the 
data from five rats within each group were pooled and inter-
group significance levels evaluated applying Student–Newman–
Keuls post hoc test; at least p < 0.05 was considered statistically 
significant.
resUlTs
Bcl-2-associated Death Promoter 
expression
Rapid eye movement sleep deprivation significantly increased 
BAD expression in the whole brain homogenate as compared to 
FMC [F(1,8) = 58.31, p < 0.001] and REC [F(1,8) = 32.03, p < 0.001] 
rat brain samples. The BAD expressions in LPC were unaffected 
and remained comparable to FMC [F(1,8) = 0.20, p < 0.66]. PRZ 
prevented the increase in BAD expression in REMSD rat brain 
[F(1,8) =  16.03, p <  0.004]; however, the levels remained higher 
[F(1,8) =  5.00, p <  0.05] than that of the sample from FMC rat 
brains (Figure 2).
cytochrome c expression
Apoptosome complex formation starts with the release of 
cytochrome c; it is a crucial step in mitochondria mediated 
apoptosis. In the present study, we observed that the cytochrome 
c levels were significantly higher in REMSD [F(1,8)  =  49.64, 
p  <  0.001] and REC groups [F(1,8)  =  115.59, p  <  0.001] as 
compared to FMC. The cytochrome c levels in LPC rat brains 
were comparable to that of FMC [F(1,8) =  1.64, p <  0.23]. PRZ 
significantly reduced cytochrome c levels in the rat brain as 
compared to REMSD [F(1,8) = 9.29, p < 0.01]; however, it could 
not completely prevent the increase, which remained higher as 
compared to FMC [F(1,8) = 19.18, p < 0.002] and LPC [F(1,8) = 8.03, 
p < 0.02] (Figure 3).
apoptosis Protease activating Factor-1 
expression
We estimated Apaf-1 in the same brain homogenate used 
for estimating BAD and cytochrome c. Western blot analysis 
showed significantly higher expression of Apaf-1 in REMSD 
[F(1,8) = 140.51, p < 0.001] and REC [F(1,8) = 22.19, p < 0.002] 
rat brains as compared to the FMC. The expressions in LPC 
rats were comparable to that of FMC [F(1,8) = 2.35, p < 0.16]. As 
compared to REMSD group, the Apaf-1 expressions decreased 
FigUre 4 | apaf-1 expression in the brain homogenate of rats under 
various conditions. Upper panel shows a representative Western blot of 
Apaf-1. Histogram in the lower panel shows percent changes in the mean 
(±SEM) band densities of the blots as compared to FMC taken as 100% in 
five sets of experiments. Abbreviations are as in the text. Significance levels 
are between the treatments of connecting horizontal bars; ***p < 0.001 and 
##p < 0.01, * as compared to FMC and # as compared to REMSD.
FigUre 3 | cytochrome c expression in the brain homogenate of rats 
under different conditions. Upper panel shows a representative Western 
blot of cytochrome c. Histogram in the lower panel shows percent changes 
in the mean (±SEM) band densities of the blots as compared to FMC taken 
as 100% in five sets of experiments. Abbreviations are as in the text. 
Significance levels are between the treatments of connecting horizontal bars; 
***p < 0.001 and ##p < 0.01, * as compared to FMC and # as compared to 
REMSD.
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in PRZ group [F(1,8) =  37.73, p <  0.001]; however, the expres-
sion continued to remain higher than in the samples from the 
FMC [F(1,8) = 43.19, p < 0.001] and LPC [F(1,8) = 9.73, p < 0.01] 
(Figure 4).
caspase9 expression
There was a significant increase in the levels of caspase9 expres-
sion in REMSD group as compared to FMC [F(1,8)  =  31.94, 
p < 0.001]; it was unaffected in the LPC [F(1,8) = 0.02, p < 0.87]. 
The significant upregulation of caspase9 continued even after 
3  days of REC [F(1,8) =  9.50, p <  0.02]. The REMSD-induced 
increase in caspase9 was significantly reduced by PRZ treatment 
[F(1,8) = 10.17, p < 0.01] as compared to REMSD, although the 
level continued to remain higher than that of FMC [F(1,8) = 65.30, 
p < 0.001] (Figure 5).
caspase3 activation
The effect of REMSD on caspase3 activation was evaluated by 
immunoblot analysis of inactive procaspase3 (32  kDa) and 
activated form of caspase3 (21  kDa). As compared to FMC, 
the REMSD significantly elevated their levels [F(1,8)  =  82.45, 
p  <  0.001] and the increase continued even after REC 
[F(1,8)  =  55.44, p  <  0.001]. In LPC rats, the levels remained 
statistically comparable with FMC [F(1,8) = 3.01, p < 0.12]. PRZ 
prevented the activation of caspase3 as compared to REMSD 
alone [F(1,8) =  13.50, p <  0.006]. Band intensities of both pro-
caspase3 (32 kDa) and cleaved Caspase3 (21 kDa) were taken 
together for evaluation (Figure 6).
Phosphorylated akt levels
We estimated the amount of Ser473 pAkt in the control and 
REMS-deprived rat brains as a measure of activation of the 
PI3-Kinase/Akt pathway. pAkt levels were reduced significantly 
in the brain sample of REMSD group as compared to FMC 
[F(1,8) = 49.67, p < 0.001]; its levels in LPC were comparable to that 
of FMC [F(1,8) = 0.01, p < 0.99]. The reduction in pAkT levels was 
prevented by PRZ and the levels were comparable to that of FMC 
[F(1,8) = 3.76, p < 0.08]. After 3 days of recovery (REC group), the 
pAkT levels returned to a level comparable to FMC [F(1,8) = 3.75, 
p < 0.08] (Figure 7).
FigUre 6 | caspase3 expressions in the brain homogenate of rats 
under different conditions. Upper panel shows a representative Western 
blot showing the presence of procaspase3 and cleaved caspase3. Histogram 
in the lower panel shows percent changes in the mean (±SEM) band 
densities, which were sum of both the Procaspase3 and cleaved caspase3 
as compared to FMC taken as 100% in five sets of experiments. 
Abbreviations are as in the text. Significance levels are between the 
treatments of connecting horizontal bars; ***p < 0.001, * as compared to 
FMC and # as compared to REMSD.
FigUre 5 | caspase9 expression in the brain homogenate of rats 
under different conditions. Upper panel shows a representative Western 
blot of caspase9. Histogram in the lower panel shows percent changes in the 
mean (±SEM) band densities of the blots as compared to FMC taken as 
100% in five sets of experiments. Abbreviations are as in the text. 
Significance levels are between the treatments of connecting horizontal bars; 
***p < 0.001 and ##p < 0.01, * as compared to FMC and # as compared to 
REMSD.
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caspase8 expression
To evaluate if extrinsic pathway could be involved in the apoptotic 
process, we estimated the level of caspase8 in the brain samples 
of REMSD and control rats. Six-day REMSD did not affect the 
caspase8 expression as compared to FMC [F(1,8) = 0.16, p < 0.69]. 
It is evident from the data that the levels remained unaffected in 
LPC [F(1,8) = 0.03, p < 0.86], REC [F(1,8) = 0.91, p < 0.36], and PRZ 
[F(1,8) = 0.02, p < 0.87] treated groups as compared to the FMC 
(Figure 8).
Tyrosine hydroxylase expression
As the effects described above were prevented by PRZ, an 
alpha1 adrenoceptor antagonist, it was obvious that NA was 
involved in the process. Further, as the effects were observed 
after several days of REMSD, we argued that the synthesis 
machinery of NA was likely to have been upregulated induc-
ing the effects. To confirm, we estimated level in control 
and REMSD rat brain samples as TH is the crucial first rate 
limiting step for the synthesis of NA. We observed that the 
TH expression was significantly higher in the REMSD rat 
brains as compared to FMC [F(1,8) = 68.69, p < 0.001] and REC 
[F(1,8) = 34.59, p < 0.001]. The expression levels in LPC were 
statistically comparable to that of FMC [F(1,8) = 2.92, p < 0.12]. 
PRZ [F(1,8) = 12.09, p < 0.008] prevented the REMSD-associated 
increase in TH expression (Figure  9) suggesting the effects 
were mediated by NA.
Th-sirna in lc-Downregulated 
Th expression
Once it was evident that NA synthesis was upregulated upon 
REMSD, the obvious follow-up question was about the source of 
NA. The LC is the primary site for NA-ergic neurons in the brain 
(23), those neurons project throughout the brain (24), they (the 
REM-OFF neurons) normally cease firing during REMS (25, 26) 
and they do not cease firing during REMSD (27). Therefore, in 
separate groups, bilateral LC was infused with either TH-siRNA 
or control siRNA and the rats were subjected to REMSD. It 
was observed that as compared to FMC, upon REMSD, TH 
FigUre 8 | caspase8 expression in the brain homogenate of rats 
maintained under different conditions. Upper panel shows a 
representative Western blot of caspase8. Histogram in the lower panel shows 
percent changes in the mean (±SEM) band densities of the blots as 
compared to FMC taken as 100% in five sets of experiments. Abbreviations 
are as in the text.
FigUre 7 | pakt expression in the brain homogenate of rats 
maintained under various conditions. Upper panel shows a 
representative Western blot of pAkt. Histogram in the lower panel shows 
percent changes in the mean (±SEM) band densities of the blots as 
compared to FMC taken as 100% in five sets of experiments. Abbreviations 
are as in the text. Significance levels are between the treatments of 
connecting horizontal bars; ***p < 0.001 and #p < 0.05, * as compared to 
FMC and # as compared to REMSD.
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expressions were upregulated in the brains of rats, which received 
control–TH-siRNA into the LC [F(1,8) = 25.18, p < 0.001]; it was 
not upregulated in the brains of rats, which received TH-siRNA; 
this supported our views (Figure 10).
Th-sirna in lc suppressed release 
of cytochrome c
We have seen above that REMSD-associated elevated NA induced 
the release of cytochrome c. This suggested activation of mito-
chondrial intrinsic pathway led to apoptosis. To confirm, we 
hypothesized that downregulation of NA synthesis by infusing 
TH-siRNA into the LC, the major source of NA in the brain and 
then subjecting the rats to REMSD, should not release cytochrome 
c. Therefore, in separate groups of chronically prepared rats, 
either control siRNA or TH-siRNA (to silence the expression of 
TH synthesis in the LC neurons) was microinjected bilaterally 
into the LC in vivo and deprived them of REMS. We observed 
that cytochrome c levels were significantly lower [F(1,8) = 114.66, 
p < 0.001] in the brains of REMS-deprived rats, which received 
TH-siRNA as compared to the rats deprived of REMS with control 
siRNA. The cytochrome c levels in the former group of rats (i.e., 
those received TH-siRNA and REMS deprived) was comparable 
to its level in the FMC [F(1,8) = 1.06, p < 0.33]. This indicates that 
the REMSD-induced elevated release of cytochrome c was medi-
ated by NA released from the LC neurons, which was prevented if 
the synthesis of NA in LC neurons was reduced by downregulat-
ing the TH synthesis (Figure 11).
TeM evaluation of Morphological changes 
in Mitochondria and nucleus in neurons 
after reMsD
Rod-shaped mitochondria with intact cristae and membrane were 
seen in the neurons in FMC and LPC groups of rats; however, they 
appeared distinctly swollen upon REMSD. The cristae appeared 
disintegrated and significantly reduced with transparent matrix 
in the REMSD rat neurons, whereas the cristae were less distorted 
in REC group of rats. The integrity of mitochondrial cristae in the 
neurons of PRZ-treated REMS-deprived rats appeared similar to 
those of FMC and LPC rats (Figure 12). The chromosomal DNA 
within the nuclei of neurons in the REMS-deprived rats appeared 
condensed and clumped along the nuclear membrane suggesting 
increased chromosomal degradation and apoptosis. Fewer neurons 
(than REMSD group) in REC and PRZ-treated groups showed 
FigUre 10 | expressions of Th in homogenate of reMsD rat brains 
after microinjection of Th-sirna or control sirna bilaterally into lc. 
Upper panel shows a representative Western blot of tyrosine hydroxylase. 
Histogram in the lower panel shows percent changes in the mean (±SEM) 
band densities of the blots as compared to FMC (without injection) taken as 
100% in five sets of experiments. Abbreviations are as in the text. 
Significance levels are between the treatments of connecting horizontal bars; 
***p < 0.001 and ###p < 0.001, * as compared to FMC and # as compared to 
TH-siRNA + REMSD.
FigUre 9 | Tyrosine hydroxylase expression in the brain homogenate 
of rats maintained under different conditions. Upper panel shows a 
representative Western blot of tyrosine hydroxylase. Histogram in the lower 
panel shows percent changes in the mean (±SEM) band densities of the 
blots as compared to FMC taken as 100% in five sets of experiments. 
Abbreviations are as in the text. Significance levels are between the 
treatments of connecting horizontal bars; ***p < 0.001 and #p < 0.05, * as 
compared to FMC and # as compared to REMSD.
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such signs of apoptosis (Figure 13). This suggested that REMSD-
associated apoptosis and neurodegeneration were induced by NA 
acting on alpha1 adrenoceptors. However, the effect was reversed 
if the NA level was naturally reduced in REC rats.
DiscUssiOn
Based on consistent and substantial evidences, it has been pro-
posed that REMS serves house-keeping function of the brain (9). 
It is affected in almost all psychosomatic disorders (28, 29) and 
neurodegenerative diseases (30–33). Prolonged REMS distur-
bance has been proposed to be a significant cause, facilitator, or 
pre-disposing factor of neurodegeneration (34). We have shown 
earlier that upon REMSD, there was significant reduction in 
cytoskeletal proteins, changes in neuronal cytomorphology, and 
in the levels of pro- and anti-apoptotic proteins, respectively, in 
the rat brain (2); however, the detailed mechanism(s) of induc-
ing such changes were unknown. Notwithstanding, it has been 
reported that cessation of the LC-NA-ergic REM-OFF neurons 
is a prerequisite for the generation of REMS (35) and if those 
neurons are kept active, REMS does not appear (36). Because of 
the latter, i.e., continuous activity of the NA-ergic neurons, the 
levels of NA increase in the brain upon REMSD and that induces 
many of the REMS loss-associated effects and symptoms from 
gene to molecule to behavior (37). Therefore, we proposed that 
elevated levels of NA could be at least a major causative factor for 
REMSD-associated neuronal apoptosis in the brain. Accordingly, 
we have studied the molecular mechanism of REMSD-associated 
NA-mediated apoptosis in the rat brain and if elevated NA induced 
such effects. We observed that in the rat brain, REMSD-induced 
apoptosis occurs by the activation of the mitochondrial intrinsic 
pathway and that is initiated by elevated level of NA acting on 
alpha1 adrenoreceptor in the brain.
The mitochondrial intrinsic pathway-induced apoptosis in 
mammals is regulated by Bcl2 family of proteins upstream of 
caspase activation (38). The Bcl2 family of proteins has either 
pro- (e.g., BAX, BAD) or anti- (e.g., Bcl2, Bcl-xl) apoptotic prop-
erty that regulates permeabilization of the outer mitochondrial 
membrane. In healthy cells, the proapoptotic factor BAD is phos-
phorylated by Akt and sequestered into the cytoplasm by the tau 
FigUre 12 | electron photo-micrograph (10,000×) showing 
mitochondrial ultrastructural changes in lc neurons of rats treated 
under various conditions. Normal elongated mitochondria can be seen in 
neurons from FMC and LPC rat brains. Images of two different rat brains after 
REMSD are shown as compared to one each from other control rat brains. 
Mitochondria appeared swollen with cristae disintegrated or reduced with 
transparent matrix in the REMSD rat brains. Cristae appeared less distorted 
in REC rat brain. In PRZ-treated group, although swelling appeared, the inner 
cristae of mitochondria appeared intact. M – mitochondria; scale bar: 
100 nm.
FigUre 11 | expressions of cytochrome c in homogenate reMsD rat 
brain after microinjection of Th-sirna or control sirna bilaterally 
into lc. Upper panel shows a representative Western blot of cytochrome c. 
Histogram in the lower panel shows percent changes in the mean (±SEM) 
band densities of the blots as compared to FMC taken as 100% in five sets 
of experiments. Abbreviations are as in the text. Significance levels are 
between the treatments of connecting horizontal bars; significance 
levels – ***p < 0.001 and ###p < 0.001, * as compared to TH-siRNA and # as 
compared to FMC.
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form of 14-3-3 protein and precludes its binding to Bcl2, thereby 
enhancing survival pathway (39). In this study, we have observed 
that upon REMSD, the levels of the survival protein pAkt were 
significantly reduced, while the un-phosphorylated BAD levels 
were significantly elevated in the rat brain; the latter is likely to be 
due to reduced levels of pAkt. BAD promotes cell death by binding 
to anti-apoptotic members of the Bcl2 family and thus inhibiting 
their survival promoting functions (40). Normally, Bcl2 interacts 
with BAX to form a complex that prevents apoptosis, while BAD 
breaks the complex releasing BAX into the cytosol favoring apop-
tosis (41). Earlier we have shown that BAX level is elevated in the 
brain under identical REMSD condition (2). Thus, it appears that 
the BAX released from the Bcl2 is translocated into the mitochon-
dria and favors apoptosis, possibly by the release of cytochrome c.
To confirm, we estimated the relative expression of cytochrome 
c in experimental (REMSD) and control rat brains and found 
that cytochrome c levels were higher in REMS-deprived rat 
brain as compared to the controls. It is known that the released 
cytochrome c promotes multimerization of Apaf-1 to form 
apoptosome complex, which sequentially recruits and activates 
initiator caspase9 (42) that elicits downstream caspase cascade 
(43). In the present study, we found that Apaf-1 and caspase9 
levels were elevated in REMSD rat brain suggesting that upon 
REMSD, the elevated Apaf-1 and cytochrome c were likely to be 
involved in apoptosome formation resulting in activation of cas-
pase9. The activation of caspase9 is known to further cleave and 
activate caspase3, thereby setting in motion the events that led to 
DNA fragmentation and cell death (44). We observed that upon 
REMSD, there was significantly higher level of caspase3 activa-
tion, a hallmark of apoptosis. The activation of caspase3 may 
take place by following two main pathways. One, the extrinsic 
route initiated by activation of the cell surface receptors leading 
directly to caspase8 activation, and two, the intrinsic pathway that 
is regulated by mitochondria (45); findings of this study support 
that the latter was active.
FigUre 13 | electron photo-micrograph (2,500×) of nucleus in lc 
neurons of rat brains treated under different conditions. Nucleus and 
chromosomes appear normal in FMC and LPC. Images of two different rat 
brains after REMSD are shown as compared to one each from other control 
rat brains. Neuron with chromatin condensation can be seen in the REMSD 
rat brains. The dark arrows point to areas near nuclear membrane with 
increased chromatin condensation. Reduced degenerative changes of 
nucleus were seen in the REC- and PRZ-treated rat brains. N – nucleus, 
NM – nuclear membrane; scale bar: 500 nm.
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In an attempt to understand the mechanism of REMSD-
induced increased apoptosis, we targeted NA as it is one of the 
key neurotransmitters regulating REMS. NA is elevated during 
REMSD, and it is responsible for many REMSD-associated cel-
lular, molecular, and psychosomatic behavioral changes (9, 46). 
Our hypothesis was indeed supported by the fact that the levels of 
all the proapoptotic proteins viz. BAD, Apaf-1, cytochrome c, and 
caspase9 were significantly reduced in PRZ-treated REMSD rat 
brains as compared to that of the untreated but deprived rat brains. 
As PRZ is an α1-adrenoceptor antagonist, the results suggest that 
the expressions of the proapoptotic proteins in the REMSD rat 
brains were induced by REMSD-associated elevated level of NA 
acting on α1-adrenoreceptors in the rat brains. However, one may 
argue that such decreased levels of the apoptotic factors were still 
statistically not comparable to their respective levels of proteins in 
the FMC and LPC rat brains. This could be because either or com-
bination of the following factors. Several days of REMSD might 
have affected other physiological processes to induce changes in 
the apoptotic factors, higher dose of PRZ possibly was required, 
other adrenoceptors and factors were involved in mediating the 
effects, and other pathways could be involved in the process and 
possible complex crosstalks among several factors and molecules 
for inducing these changes.
To re-confirm further that increased apoptosis was due to 
REMSD-associated elevated levels of NA in the brain and in an 
attempt to simulate the condition in vivo, we hypothesized that 
manipulation of the brain NA-ergic system, which is critically 
involved in REMS regulation would induce the REMSD-associated 
changes. As it was known that cessation of NA-ergic LC neurons 
is a prerequisite for REMS regulation, those neurons do not 
cease activity during REMSD; NA from those neurons induces 
several other REMSD-associated effects, and NA-synthesizing 
enzyme (i.e., TH) is increased upon REMSD (9, 46, 47); we 
hypothesized that if NA synthesis was downregulated, REMSD 
should not be able to express the REMSD-associated effects in 
spite of behavioral REMSD. Accordingly, while depriving, the 
NA synthesis from LC neurons was downregulated in  vivo by 
local microinjection of TH-siRNA bilaterally into the rat LC. 
As TH levels were significantly reduced in the brains of these 
rats, it may be inferred with reasonable certainty that NA levels 
were significantly reduced in them. Further, indeed in these rats, 
cytochrome c levels did not increase even after REMSD although 
cytochrome c levels remained elevated in the REMS-deprived 
rats that received control siRNA in the LC. It was technically not 
possible to confirm the microinjection site and at the same time 
use the brain homogenate for estimation of other proteins from 
the same brain sample. However, using reductionist approach of 
findings from various control as well as pilot experiments, it can 
be said with reasonable confidence that the microinjections were 
in the LC. For example, if the microinjections were not in the 
LC, reduction in TH in LC-injected rats, but not in control rats 
(Figure 10), cannot be justified. All these findings taken together 
suggest that upon REMSD, the NA level increases in the brain 
and the elevated level of NA induces cytochrome c level, which in 
turn induces neuronal apoptosis in the brain. Further, REMSD-
induced apoptosis followed mitochondrial intrinsic pathway 
as caspase9, caspase3, and cytochrome c were elevated, while 
caspase8 remained unaffected. Since changes in cytochrome c 
levels play a pivotal role in the mitochondrial intrinsic pathway, 
we estimated its levels in TH-siRNA-injected REMS-deprived 
rat brains. As critical argument, it may be emphasized that TH 
silencing at least inhibits initiation of intrinsic apoptotic pathway 
in REMS-deprived rats in particular.
In many chronic neuropathological conditions, the REMS 
is reported to decrease with associated loss of LC neurons (34, 
48). The latter effect is likely to reduce NA in the LC projection 
areas in such chronic condition; however, it would depend on 
the proportion of NA-ergic cell loss, their recovery, efficiency of 
NA synthesis, and so on. Our views may be supported by the fact 
that no change, significantly reduced or elevated levels, of NA 
in the brain and cerebrospinal fluid of the Alzheimer’s patients 
have been reported (48–50). We argue that in most such neuro-
pathological condition, if not all, at least initially (at the onset), 
the REMS is decreased raising the level of NA in the brain. If 
the elevated level of NA is sustained without compensation (con-
trol), neuronal apoptotic process sets-in giving rise to varieties 
of symptoms, which depend on sensitivity, predisposition, brain 
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area, number of neurons damaged, and so on. Notwithstanding, 
it is also possible that the NA level might increase in the brain 
for various reasons including life style and other diseases causing 
reduced REMS, which then reinforces elevated levels of NA lead-
ing to apoptosis. We have dealt with neural mechanism of REMS 
regulation and elevation of NA upon REMSD at length elsewhere 
(9, 46, 47). Because of the above, naturally the symptoms vary, 
although reduced REMS remains a common associated symptom 
in neurodegenerative diseases and level of NA would depend on 
the chronicity of the case, how many LC neurons are effectively 
damaged, how much NA synthesis is affected, and so on by the 
time the patients reach the clinics. Thus, although desirable, it 
may be difficult to track the sequence of cause and effect events 
in patients; however, reduced REMS and elevated level of NA 
cannot be denied, which then initiates apoptosis; its molecular 
mechanism has been traced in this study.
Rats were REMS deprived by the flower pot method, the most 
preferred method for inducing experimental REMSD. Earlier 
we have discussed in detail the advantages and disadvantages of 
this method (51), where the former outweighs the latter. By this 
method, non-REMS is also significantly reduced if the depriva-
tion is continued for 24 and 48 h; however, REMS is maximally 
reduced and non-REMS is least affected (comparable to that of 
LPC rats), if the deprivation is continued for longer period as has 
been done in this study. Notwithstanding, a common criticism 
of most behavioral studies is induction of possible stress to the 
subjects caused by the experimental manipulation, and this study 
too cannot escape from the same criticism. The rats undergoing 
REMSD may experience stress due to restricted movement, social 
isolation, and muscular overactivity. To rule out the effects of such 
non-specific factors confounding the results, we have used LPC 
and REC. Earlier, using the same method, we have shown that at 
least for Na-K ATPase activity, the effects were due to REMSD 
and not due to other non-specific factors (52). Although stress has 
been defined and characterized in more than one way, some studies 
have correlated stress to elevated levels of NA and corticosterone 
(53, 54). REMSD-associated elevation of NA level can be explained 
by the fact that the NA-ergic REM-OFF neurons, which normally 
cease activity during REMS, continue activity during REMSD (27, 
46). Therefore, in this study, we have investigated the effect of NA 
on neuronal apoptosis. As the REMSD-associated effects were 
prevented by NA-ergic antagonist, PRZ and by downregulation of 
NA synthesis in the LC neurons, it is reasonable to infer that the 
observed effects were due to the elevated levels of NA acting on 
alpha1 adrenoceptors. The effect of PRZ per se may be ruled out 
as PRZ treatment is reported to induce TH expression (55) rather 
than decrease, as has been observed in this study. As corticoster-
one is neither directly involved in the regulation of REMS nor 
(more importantly) its level increases upon REMSD even using the 
method we have used (5, 37, 56, 57), it is highly improbable that 
the effects observed in this study were induced by corticosterone.
The levels of proapoptotic proteins in the LPC rat brains 
were comparable to respective FMC levels, suggesting that the 
changes observed in the experimental REMS-deprived rat brains 
were not due to non-specific factors. Further, the observed effects 
were specific to REMSD because most of the induced effects (e.g., 
pAkt) either returned or tended to return toward the baseline 
(FMC) level after the rats were allowed to recover (REC) from the 
lost REMS. The effects were not induced by non-specific factors 
because some of the proteins remained unaffected (e.g., caspase8) 
after REMSD; all the effects were not affected uniformly and some 
of the changes (e.g., BAD, cytochrome c, Apaf-1, caspase9, and 
caspase3) did not return completely to the FMC (basal) level in 
REC rats. The latter could be because the threshold of recovery 
time may differ for different proteins (factors) and possibly more 
time was necessary for recovery.
Rapid eye movement sleep deprivation affected the molecules 
under study in the whole brain homogenate. This suggested that 
REMSD exerts a generalized effect in most neurons throughout 
the brain and it explains why REMSD affects most of the physi-
ological processes globally in the body particularly controlled by 
the brain. However, the intensity of effects differs possibly due 
to sensitivity and predisposition of the affected neurons as well 
as the physiological processes. These views may be supported by 
the fact that LC projects to all parts of the brain (58), and we have 
reported that the effects of REMSD start from localized region 
and then spread to different regions in the brain with increase in 
duration of REMSD (59). At the molecular level, it can be further 
attributed that executioner caspase (e.g., caspase3) is autocatalyti-
cally activated and once the level of the mitochondrial apoptotic 
signaling reached a critical value, “a set-point or a point of no-
return,” the effect of anti-apoptotic Bcl-2 protein escapes exerting 
protecting effect; however, it does not follow all and none law. 
Furthermore, interestingly, as most of the changes returned or 
tended to return upon recovery of REMS (e.g., pAkt), it reflects 
that apoptosis is not an irreversible process and quite logically 
there are self-rectifying physiological processes, which when fails 
(point of no-return), apoptotic damage is initiated.
Perturbations in mitochondrial respiration can occur early in 
the apoptotic process; mitochondria itself may serve as a control 
switch at least for some form of apoptosis (60). Mitochondrial 
shape, size, and numbers vary within neurons and synapses. 
To substantiate our findings, we carried out TEM studies to 
qualitatively evaluate the physical damage to the mitochondria, 
the shape, and intactness (breakage) of cristae, in particular. Our 
TEM results showed physical damage in the mitochondrial ultra-
structure in REMS-deprived rats. Swelling of the mitochondrial 
matrix was observed in the LC neurons upon REMSD. Such 
mitochondrial changes have been reported to be the immedi-
ate cause of cytochrome c release (61), which further supports 
our findings of elevated cytochrome c level in the brain after 
REMSD. Mitochondrial impairment has been shown to promote 
apoptotic cell death with depolarization associated with release 
of apoptosis-inducing factor and cytochrome c, and activation 
of procaspases (62). Recently, reduced levels of SirT3 have been 
correlated to reduced number of neurons in mice kept awake (63, 
64). As increased waking is associated with REMSD, whether the 
effects seen in this study could have any association/relation with 
Sirt3 levels need further study.
The ultrastructural changes in the mitochondria were induced 
by REMSD-associated elevated level of NA in the brain because 
the effects were reduced by PRZ, and it showed partial recovery 
with post-REMSD recovery of REMS, when the level of NA 
returned to normal level. Although apparently, there might be 
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minor differences in the size of mitochondria in the FMC and 
LPC rat brains, they were generally elongated (not round or 
oval) and cristae were mostly intact. A complete reversal of 
the mitochondrial physical characteristics to normal elongated 
shape was not seen after 3 days of REC. This is possibly because 
more time was needed for complete recovery, which may be sup-
ported by the fact that cytochrome c levels remained elevated in 
REC- and PRZ-treated rat brains as compared to FMC and LPC. 
The morphological changes in the mitochondria support that 
REMSD-associated apoptotic changes (2) follow mitochondrial 
intrinsic pathway and the effects were mediated by NA acting on 
alpha1 adrenoreceptor.
Reduction in pAkt by NA upon REMSD may be justified by 
the fact that Akt has been reported to promote cell survival (65, 
66). Although we have not studied its intracellular mechanism 
of action directly in this study, based on our previous reports 
under similar condition and supported by other findings, it may 
be explained as follows. Ca2+ plays a role in phosphorylation 
of Akt for its activation (67). We have reported reduction in 
intra-synaptosomal Ca2+ level under similar REMSD condition 
(68) and NA reduces Ca2+ influx (69). Therefore, combining our 
previous observations and findings of this study, we conclude that 
REMSD elevates NA, which in turn reduces Ca2+ influx result-
ing in reduced phosphorylation of Akt. The latter activates BAD 
triggering mitochondrial intrinsic pathway resulting neuronal 
apoptosis, while BAD combining with Bcl2 inhibits neuronal 
survival (Figure 14). We also propose that intensity and severity 
of REMSD would depend on synergism of effects and predisposi-
tion of the affected neurons to induce pathophysiological changes. 
If the catastrophic cascade at the molecular level would reach a 
point of no-return (set-point), neurodegeneration would be initi-
ated. However, the silver lining is that the effects may be prevented 
by compensating lost REMS and/or by reducing NA synthesis by 
possible therapeutic intervention, which we have shown as a proof 
of principle.
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FigUre 14 | We have shown earlier that reMsD increases apoptosis in the rat brain and that is mediated by reMsD-associated elevated na level in 
the brain (1). We have also shown that REMSD reduces intracellular Ca2+ (68) and NA reduces Ca2+ influx (69). Combining those findings with the results of this 
study that the REMSD-associated neuronal apoptosis follows mitochondrial intrinsic pathway, we have traced the molecular pathway, which has been schematically 
represented in this figure.
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